STAT3 and neurodegenerative disease: The enhancement of CREB phosphorylation and the upregulation of IEGs associated with synaptic plasticity and memory formation suggest that STAT3 inhibitors hold promise not only for mitigating cell death but also for supporting cognitive function in neurodegenerative diseases.